Innovative Medical Focus Obalon specializes in high-quality gastric balloon technology, with a strong emphasis on innovation in medical devices for weight management. This focus indicates potential opportunities to collaborate with medical clinics and health systems seeking cutting-edge obesity treatment solutions.

Recent Merger Growth The recent merger with ReShape Lifesciences has expanded Obalon's market footprint and product portfolio, presenting opportunities for cross-selling advanced weight loss technologies to existing clients and exploring new market segments in obesity treatment.

Funding & Revenue With a funding level of $17 million and revenue between $1 million and $10 million, Obalon demonstrates growth potential, making it an attractive partner for investors and suppliers aiming to engage with a nimble company that is scaling its market presence.

Regulatory and Legal Activity Active investigations and legal proceedings related to securities law and fiduciary duties suggest the company is navigating complex regulatory environments, indicating a need for compliant technological solutions or consulting services to support governance and transparency.

Technology Stack and Digital Engagement Obalon's use of diverse digital tools such as Microsoft Dynamics and Adobe Creative Suite signals a readiness to adopt innovative technology solutions, providing openings for sales pitches around software for sales enablement, customer engagement, and marketing automation.